The value of MGMT promote methylation and IDH-1 mutation on diagnosis of pseudoprogression in patients with high-grade glioma: A meta-analysis

OBJECTIVE: To date, there are several published studies on the value of IDH-1 (isocitrate dehydrogenase-1) mutation and MGMT (O6-Methylguanine-DNA methyltransferas) promoter methylated status on the diagnosis of pseudoprogression (PSP) and true tumor progression after or within chemo-radiotherapy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Min, Niu, Chaoshi, Jia, Li, He, Hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
4100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922590/
https://www.ncbi.nlm.nih.gov/pubmed/31852075
http://dx.doi.org/10.1097/MD.0000000000018194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922590/
https://www.ncbi.nlm.nih.gov/pubmed/31852075
http://dx.doi.org/10.1097/MD.0000000000018194

Ejemplares similares